Aegis Initiates Buy On Microvision, Calls PicoP Technology 'A Leader In Fast Growing Market'

Loading...
Loading...
Aegis Capital initiated coverage on
Microvision, Inc. MVIS
with a Buy rating, viewing the company's PicoP technology as a leader in the fast growing market.
According to the analysts, the optical engine, capable of both miniature projection and sensing three dimensional images, have a compact design (about the size of a quarter) that allows it to incorporate into end products with diminutive form factors.

Related Link: MicroVision Reports Q2 EPS $(0.07), Inline, Sales $4.2M vs $3M Est.

"Market researchers believe this market could grow at a CAGR of nearly 40 percent out to 2022, reaching an aggregate value of nearly $18 billion worldwide at that time," wrote Aegis.

The analysts noted that the company's end products utilizing MicroVision's technology are in the early stages of commercialization, therefore it is hard to forecast product sales. However, they believe revenue growth should at least keep pace with the market, which is expected to grow at a 40 percent clip over the next few years.

The analysts estimate 2016 and 2017 revenues to stand at $16 million and $24 million and the loss per share at $0.28 and $0.19, respectively. Aegis suggests a $2.90 price target on the company's shares, which is based on a multiple of 5 times their 2018 revenue estimate.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasInitiationAnalyst RatingsTechTrading IdeasAegis Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...